 The credit facility will enable Cellectis to support the development of its UCART product candidates pipeline The credit facility consists of three tranches of 20 million, 15 million, and 5 million respectively, each redeemable in fine in 6 years The credit facility is part of the European Investment Banks strategy to support biotech companies developing a high-level ... The post Cellectis secures a 40 million credit facility from the European Investment Bank to support its Research, Develo... 